Biolux Technology, a leader in orthodontic innovation, has secured $4.5 million in seed funding to launch a digital platform for OrthoPulse, improve treatment options, and expand operations. The investment, led by redalpine and Revere Partners, will allow Biolux to enhance OrthoPulse with real-time monitoring and optimized treatment capabilities. In addition, Raphael Pascaud has been appointed as Chairman to guide the company through its next phase of growth.
The new digital platform for OrthoPulse will revolutionize orthodontics by providing orthodontists and patients with advanced monitoring and treatment options. Mr. Pascaud, with his extensive experience in the dental industry, will help navigate Biolux through its expansion plans and further innovation.
The latest funding will also support the development of OrthoPulse’s patented light-accelerated technology, which accelerates tooth movement for faster and more reliable treatment. This approach aims to reduce treatment time and improve patient outcomes, addressing key issues in orthodontic care.
“We are excited to partner with redalpine and Revere Partners and welcome Raphael Pascaud as our Chairman,” said Marcel Pordes, CEO of Biolux Technology. “This investment marks a significant milestone in our mission to transform orthodontics. We are dedicated to providing efficient treatment options for patients and empowering orthodontists with the tools they need to deliver exceptional care.”
With support from leading investors and innovative technology, Biolux Technology is poised for rapid growth and success in the orthodontic market.
Source
Photo credit orthodonticproductsonline.com